Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index; 23 of the 40 sources its claims cite were checked for support.

Diagnostic accuracy of biomarkers to detect acute mesenteric ischaemia in adult patients: a systematic review and meta-analysis

Open access
Reintam Blaser, Annika, Starkopf, Joel, Björck, Martin, Forbes, Alastair, Kase, Karri, Kiisk, Ele, Laisaar, Kaja-Triin, Mihnovits, Vladislav, Murruste, Marko, Mändul, Merli, Voomets, Anna-Liisa, Tamme, Kadri · 2023 · World Journal of Emergency Surgery

Published version of a preprint

Abstract

Systematic review and meta-analysis assessing biomarkers for diagnosis of AMI in adults.

Overview

CoChat Summary

## TL;DR

This systematic review and meta-analysis found that no single biomarker had sufficient diagnostic accuracy to diagnose acute mesenteric ischaemia (AMI) in adults. Some biomarkers, especially inflammatory markers and I-FABP, showed moderate predictive value, but the evidence was highly heterogeneous and at high risk of bias.

## Key findings

  • 75 studies with 9,914 patients were included in quantitative analyses, and 18 biomarkers in serum/plasma plus 1 urine biomarker were meta-analyzed.
  • None of the biomarkers reached a “conclusive level” for accurate prediction; the best overall results were reported for ischaemia-modified albumin (2 studies, sensitivity 94.7%, specificity 90.5%), interleukin-6 (n = 4, 96.3% and 82.6%), procalcitonin (n = 6, 80.1% and 86.7%), and serum I-FABP (n = 16, 73.9% and 90.5%) or urinary I-FABP (n = 4, 87.9% and 78.9%).
  • For transmural mesenteric ischaemia, urinary I-FABP (n = 2, 92.3% and 85.2%) and D-dimer (n = 3, 87.6% and 83.6%) showed moderate predictive value.
  • The overall risk of bias was high, mainly because of selected study populations and unclear timing of biomarker measurement after symptom onset.

## Methods

  • Systematic review and meta-analysis following PRISMA, registered in PROSPERO (CRD42022379341); searches were run on 19 Dec 2022 in PubMed, Cochrane Library, Web of Science, and Scopus, with no date or language restriction.
  • Included adult patients (>18 years) with suspected AMI; studies had to include at least 10 adult patients and report diagnostic accuracy data for biomarkers measured in blood/serum/plasma or urine, with AMI confirmed by surgery, CT-angiography, angiography, endoscopy, or histopathology/autopsy.
  • Two reviewers independently screened, extracted data, and assessed quality with QUADAS-2; random-effects meta-analyses pooled sensitivity, specificity, and likelihood ratios, with predefined subgroups by AMI type, stage (any stage vs transmural), and biomarker timing.

## Limitations

  • Stated by the paper: included studies were heterogeneous in patient populations, AMI types, laboratory methods, biomarker cut-offs, and often did not report timing from symptom onset to biomarker measurement; all studies were judged at some risk of bias and/or with concerns about applicability.
  • Stated by the paper: the authors could not clearly separate non-transmural from transmural AMI, or vascular AMI from SBO, in their analyses.
  • Evident from the text: many biomarkers had only one eligible study, and combinations of biomarkers were rarely studied, so several analyses could not be meta-analyzed.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1186/s13017-023-00512-9

Cites

104 of 104 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 PRISMA Flow diagram
Fig. 1 PRISMA Flow diagramCC BY · PubMed Central
Fig. 2 Sensitivity (panel A) and specificity (panel B) of serum intestinal fatty acid-binding protein (I-FABP) predicting AMI. AMI—acute mesenteric ischaemia; NOMI—non-occlusive mesenteric ischaemia; SBO—strangulated bowel disease. Any stage—studies assessing different stages of AMI, including but not limited to non-transmural and transmural; Transmural—studies assessing transmural AMI, with control group including non-transmural AMI. Comment: Uzun 2014 included healthy volunteers as control. Hycult—Hycult Biotech measurement kit from Uden, the Netherlands. Osaka—D.S. Pharma Biomedical measurement kit from Osaka, Japan. R&D—R&D Systems measurement kit from Minneapolis, USA
Fig. 2 Sensitivity (panel A) and specificity (panel B) of serum intestinal fatty acid-binding protein (I-FABP) predicting AMI. AMI—acute mesenteric ischaemia; NOMI—non-occlusive mesenteric ischaemia; SBO—strangulated bowel disease. Any stage—studies assessing different stages of AMI, including but not limited to non-transmural and transmural; Transmural—studies assessing transmural AMI, with control group including non-transmural AMI. Comment: Uzun 2014 included healthy volunteers as control. Hycult—Hycult Biotech measurement kit from Uden, the Netherlands. Osaka—D.S. Pharma Biomedical measurement kit from Osaka, Japan. R&D—R&D Systems measurement kit from Minneapolis, USACC BY · PubMed Central
Fig. 3 Sensitivity (panel A) and specificity (panel B) of white blood cell count (WBC) predicting AMI. AMI—acute mesenteric ischaemia; NOMI—non-occlusive mesenteric ischaemia; SBO—strangulated bowel disease. Any stage—studies assessing different stages of AMI, including but not limited to non-transmural and transmural; Transmural—studies assessing transmural AMI, with control group including non-transmural AMI
Fig. 3 Sensitivity (panel A) and specificity (panel B) of white blood cell count (WBC) predicting AMI. AMI—acute mesenteric ischaemia; NOMI—non-occlusive mesenteric ischaemia; SBO—strangulated bowel disease. Any stage—studies assessing different stages of AMI, including but not limited to non-transmural and transmural; Transmural—studies assessing transmural AMI, with control group including non-transmural AMICC BY · PubMed Central
Fig. 4 Sensitivity (panel A) and specificity (panel B) of serum D-dimers predicting AMI. AMI—acute mesenteric ischaemia; NOMI—non-occlusive mesenteric ischaemia; SBO—strangulated bowel disease. Any stage—studies assessing different stages of AMI, including but not limited to non-transmural and transmural; Transmural—studies assessing transmural AMI, with control group including non-transmural AMI
Fig. 4 Sensitivity (panel A) and specificity (panel B) of serum D-dimers predicting AMI. AMI—acute mesenteric ischaemia; NOMI—non-occlusive mesenteric ischaemia; SBO—strangulated bowel disease. Any stage—studies assessing different stages of AMI, including but not limited to non-transmural and transmural; Transmural—studies assessing transmural AMI, with control group including non-transmural AMICC BY · PubMed Central
Fig. 5 Sensitivity (panel A) and specificity (panel B) of blood L-lactate predicting AMI. AMI—acute mesenteric ischaemia; NOMI—non-occlusive mesenteric ischaemia; SBO—strangulated bowel disease. Any stage—studies assessing different stages of AMI, including but not limited to non-transmural and transmural; Transmural—studies assessing transmural AMI, with control group including non-transmural AMI
Fig. 5 Sensitivity (panel A) and specificity (panel B) of blood L-lactate predicting AMI. AMI—acute mesenteric ischaemia; NOMI—non-occlusive mesenteric ischaemia; SBO—strangulated bowel disease. Any stage—studies assessing different stages of AMI, including but not limited to non-transmural and transmural; Transmural—studies assessing transmural AMI, with control group including non-transmural AMICC BY · PubMed Central

Verification

Claims the paper makes

15 Valid · 0 Not valid · 12 Not checked · 36 Own results and interpretations

39 more claims · 4 with their cited sources checked

Create a free account to see all 63 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 14
  • The quote only partly states this claim. 5

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

5 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 102 references

Research works printed but not linked: 1

  1. Beng Fuh R, Eisele R. Acute disturbance of the mesenterial circulation. What is the diagnostic value of easily performed preoperative tests? Chirurgische Praxis. 2004;63(4):573–83.

Cited by

See all 67

Metadata

Authors
Reintam Blaser, A., Starkopf, J., Björck, M., Forbes, A., Kase, K., Kiisk, E., Laisaar, K.-T., Mihnovits, V., Murruste, M., Mändul, M., Voomets, A.-L., & Tamme, K.
Affiliations
  • Tartu University Hospital (EE)
  • Uppsala University (SE)
  • University of Tartu (EE)
Venue
World Journal of Emergency Surgery
Published
2023-09-01
Volume
18
Issue
1
Pages
44-44
ISSN
1749-7922 (ISSN-L)
OpenAlex
W4386378232
Cited by
67
References
102
Citations by year
2026: 20 · 2025: 25 · 2024: 22
FWCI
4.39
Type
journal article
Language
en
Open access
Licence
Locations
  • World Journal of Emergency Surgery (publishedVersion, cc-by)
  • Research Square (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • KTH Publication Database DiVA (KTH Royal Institute of Technology) (submittedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Eesti Teadusagentuur (PRG1255)
Topics
  • Health Sciences › Medicine › Surgery › Abdominal vascular conditions and treatments
  • Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
  • Health Sciences › Medicine › Emergency Medicine › Appendicitis Diagnosis and Management
Keywords
acute mesenteric ischemia, diagnostic biomarkers, diagnostic accuracy, ischemia-modified albumin, interleukin-6, procalcitonin, intestinal fatty acid binding protein, D-dimer, serum biomarkers, urinary biomarkers, sensitivity and specificity, likelihood ratios, adult patients, combined biomarker detection, risk of bias
MeSH terms
Adult, Humans, Necrosis, Serum Albumin, Biomarkers, Interleukin-6, Mesenteric Ischemia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Diagnostic accuracy of biomarkers to detect acute mesenteric ischaemia in adult patients: a systematic review and meta-analysis. https://app.cochat.ai/papers/10.1186/s13017-023-00512-9
The paper
Reintam Blaser, A., Starkopf, J., Björck, M., Forbes, A., Kase, K., Kiisk, E., Laisaar, K.-T., Mihnovits, V., Murruste, M., Mändul, M., Voomets, A.-L., & Tamme, K. (2023). Diagnostic accuracy of biomarkers to detect acute mesenteric ischaemia in adult patients: a systematic review and meta-analysis. World Journal of Emergency Surgery. https://doi.org/10.1186/s13017-023-00512-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.